Effect of interferon therapy on Japanese chronic hepatitis C virus patients with anti-liver/kidney microsome autoantibody type 1

Journal of Gastroenterology and Hepatology (Australia)

Volumn 16, Issue 7, 2001, Pages 782-788

  Iijima, Yoshihiko ^a   Kato, Takanobu ^b   Miyakawa, Hiroshi ^c   Ogino, Masataka ^a   Mizuno, Makoto ^a   Sugihara, Kanji ^a   Ando, Takahiro ^a   Fujiwara, Kei ^a   Orito, Etsuro ^b   Ueda, Ryuzo ^b   Mizokami, Masashi ^b  

^a NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

Author keywords

Autoantibody; Chronic hepatitis; Enzyme linked immunosorbent assay; Hepatitis C virus; Interferon

Indexed keywords

AUTOANTIBODY; GAMMA INTERFERON;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOREACTIVITY; JAPAN; KIDNEY MICROSOME; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER MICROSOME; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; SIGNAL DETECTION;

EID: 18244399903     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2001.02513.x     Document Type: Article

References (21)

1. Chronic active hepatitis associated with anti-liver/kidney microsome type 1: A second type of 'autoimmune hepatitis'
2. Type II autoimmune hepatitis and hepatitis C virus infection
3. Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM)
4. Anti-GOR and hepatitis C virus in autoimmune liver disease
5. Liver/kidney microsome antibody type 1 and hepatitis C virus infection
6. Autoimmune chronic hepatitis exacerbated by alpha-interferon
7. Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C
8. Efficacy and safety of interferon Alpha therapy with hepatitis C with autoantibodies to liver-kidney microsomes
9. Detection of anti-LKM-1 (anti-CYP2D6) by an enzyme-linked immunosorbent assay in adult patients with chronic liver disease
10. A second-generation method of genotyping hepatitis C virus by the polymerase chain reaction with sense and antisense primers deduced from the core gene
11. Frequency and significance of antibodies to P4502D6 protein in Japanese patients with chronic hepatitis C
12. Absence of anti-LKM antibody in hepatitis C viral infection in the United States of America
13. Antibodies to hepatitis C virus in autoimmune liver diseases: Evidence for geographical heterogeneity
14. Chronic hepatitis C associated with anti-liver/kidney microsome-1 antibody is not a subgroup autoimmune hepatitis
15. Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2
16. Reactivity of sera from Japanese patients with type 2 autoimmune hepatitis to peptides derived from host genes, Cytochrome HLD8.2, and GOR
17. Liver/Kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane
18. Steroid and interferon therapy in liver/kidney microsomal antibody-positive patients with chronic hepatitis C
19. Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C
20. Type 2 autoimmune hepatitis and hepatitis C virus infection
21. Interferon therapy in LKM-1 positive patients with chronic hepatitis C: Follow up by a quantitative radioligand assay for CYP2D6 antibody detection